Pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?
The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. (Twenty-three thousand die.) These experiences leave deep impressions not just on the patients but on their family and friends.
Michael Kinch, PhD, associate vice chancellor and director of the Center for Research Innovation in Business, is among that number. A few years ago his 12-year-old son suddenly became ill, so ill Kinch had to carry him into a nearby clinic in his arms. Because his son had a fever, the doctors at the clinic put him on first one and then a second antibiotic while they worked on a diagnosis.
They soon learned his son’s appendix had burst and he was septic. “Things moved so fast he was septic before he was symptomatic [for appendicitis],” Kinch said. His son was moved to an academic medical center where he had surgery and was put on four newer antibiotics.
When the lab tests for antibiotic susceptibility finally came in, they showed the pathogenic bacteria were susceptible to only two of the six antibiotics Kinch’s son had been given. Stunningly, the two that worked were the older drugs he had been given at the clinic. “I can only assume that if we had gone straight to the academic medical center, he might not have survived,” Kinch said.
“It’s not that my son had had extensive exposure to antibiotics,” Kinch explained carefully. “We’re all just colonized by resistant bacteria now.”
“Three weeks later I was asked to join a nonprofit organization working on new models for drug development, called the Institute for Life Sciences Collaboration,” Kinch said. “The institute was picking the therapeutic areas that would be their focus. “They were considering various exotic diseases, and I said, ‘Antibiotics.’”
Antibiotics are crashing.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Europe Antibiotics Market 2021 -2030, By Size, Supplier, Demand Analysis, Type, Statistics, Regions and Industry Key Manufactureon November 24, 2020 at 9:56 pm
Europe antibiotics market accounted for $11.65 billion in 2019 and will grow by 3.4% annually over 2020-2030 owing to ...
- North America Antibiotics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021 - 2030on November 24, 2020 at 9:56 pm
North America antibiotics market is expected to grow by 2.3% annually in the forecast period and reach $14.67 billion ...
- Global Antibiotics Market to Grow by $4.44 Billion During 2020-2024 | Rising Prevalence of Infectious Diseases to Boost Growth | Technavioon November 24, 2020 at 9:30 pm
The global antibiotics market size is expected to grow by USD 4.44 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. According to the latest research report by ...
- Global Antibiotics Market to Grow by $4.44 Billion During 2020-2024 | Rising Prevalence of Infectious Diseases to Boost Growthon November 24, 2020 at 5:35 pm
Rising Prevalence of Infectious Diseases to Boost Growth \| Technavio Business Wire LONDON -- November 24, 202 ...
- Insights in the search for new antibioticson November 19, 2020 at 4:58 pm
A collaborative research team published an opinion article that addresses the gap in the discovery of new antibiotics.
- Researchers present insights in the search for new antibioticson November 19, 2020 at 1:24 pm
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that ...
- Antibiotics Before Age 2 May Up Odds for Obesity, Allergieson November 18, 2020 at 3:22 pm
Antibiotics Before Age 2 May Up Odds for Obesity, Allergies WEDNESDAY, Nov. 18, 2020 (HealthDay News) -- Kids given antibiotics before their second birthday may have a heightened risk for chronic ...
- Study warns against overuse of antibiotics in kids under 2, but experts say the drugs 'save lives' when used correctlyon November 18, 2020 at 7:06 am
A study published in the journal Mayo Clinic Proceedings sparked concern Monday that antibiotic use among children under two may increase the risk of health issues later in life, including asthma, ...
- Antibiotics in Kids Under 2 Associated with Chronic Conditionson November 17, 2020 at 8:01 am
Children under age 2 who take antibiotics are at greater risk for childhood-onset asthma, respiratory allergies, eczema, celiac disease, obesity and attention deficit hyperactivity disorder ...
- Study: Antibiotics before age 2 associated with later health problemson November 16, 2020 at 5:40 pm
An observational study has linked the use of antibiotics before the age of 2 with an elevated risk of a developing wide range of health conditions later on during childhood. The retrospective case ...
via Bing News